Nucleozin 255 Smiles: CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(Br)C2=C1N=CN=C2N)CCCNC(=O)NC1C=CC(=CC=1)C(C)(C)C

Smiles: CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(Br)C2=C1N=CN=C2N)CCCNC(=O)NC1C=CC(=CC=1)C(C)(C)C

InChi: InChI=1S/C18H13Cl2N3O3S/c19-13-5-1-2-6-15(13)23-27(25

PubMed PMID: 21966423

often upregulated or mutated in a variety of cancer cells

This includes research in respiration where it is believed that A2A receptors are involved in rhythm generation in the pre-Bötzinger complex

Nucleozin 255 Smiles: CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(Br)C2=C1N=CN=C2N)CCCNC(=O)NC1C=CC(=CC=1)C(C)(C)CNucleozin is an antivirus agent. Nucleozin targets influenza A nucleoprotein (NP), a multifunctional, RNA binding protein necessary for virus replication. Nucleozin is effective in fighting H1N1, H3N2, and H5N1 flu virus strains by inducing the formation of NP aggregates and antagonizing its nuclear accumulation, leading to cessation of viral replication. Product information CAS Number: 341001 38 5 Molecular Weight: 426. 85 Formula: C21H19ClN4O4